Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9

Biochemical and Biophysical Research Communications

Volumn 402, Issue 4, 2010, Pages 663-669

  Ohta, Mariko ^a   Ishida, Akiko ^a   Toda, Munetoyo ^a   Akita, Kaoru ^a   Inoue, Mizue ^a   Yamashita, Keishi ^b   Watanabe, Masashi ^b   Murata, Takeomi ^c   Usui, Taichi ^c   Nakada, Hiroshi ^a  

^a KYOTO SANGYO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHIZUOKA UNIVERSITY   (Japan)

Author keywords

Dendritic cell; IL 12; Immunomodulation; Mucin; Siglec 9

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MUCIN; POLYMER; SIGLEC 9 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSURVEILLANCE; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; UPREGULATION;

ANTIGENS, CD; CARCINOMA; CELL LINE, TUMOR; DENDRITIC CELLS; HUMANS; IMMUNOMODULATION; LECTINS; MONOCYTES; MUCINS; NEOPLASMS; TUMOR ESCAPE;

EID: 78649445696     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.10.079     Document Type: Article

References (29)

1. Banchereu J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
2. McCoy K., Camberis M., Gros G.L. Protective immunity to nematode infection is induced by CTLA-4 blockade. J. Exp. Med. 1997, 186:183-187.
3. Gabrilovich D.I., Ciernik I.F., Carbone D.P. Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. Cell. Immunol. 1996, 170:101-110.
4. Chaux P., Favre N., Martin M., et al. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int. J. Cancer 1997, 72:619-624.
5. Gabrilovich D.I., Corak J., Ciernik I.F., et al. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin. Cancer Res. 1997, 3:483-490.
6. Radmayr C., Bock G., Hobisch A., et al. Dendritic antigen-presenting cells from the peripheral blood of renal-cell-carcinoma patients. Int. J. Cancer 1995, 63:627-632.
7. Kim Y.S., Gum J., Brockhausen I. Mucin glycoproteins in neoplasia. Glycoconj. J. 1996, 13:693-707.
8. Miyake M., Taki T., Hitomi S., et al. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N. Engl. J. Med. 1992, 327:14-18.
9. Toda M., Akita K., Inoue M., et al. Down-modulation of B cell signal transduction by ligation of mucins to CD22. Biochem. Biophys. Res. Commun. 2008, 372:45-50.
10. Toda M., Hisano R., Yurugi H., et al. Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells. Biochem. J. 2009, 417:673-683.
11. Mukherjee P., Ginardi A.R., Madsen C.S., et al. MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment. Glycoconj. J. 2001, 18:931-942.
12. Apostolopoulos V., Loveland B.E., Pietersz G.A., et al. CTL in mice immunized with human mucin 1 are MHC-restricted. J. Immunol. 1995, 155:5089-5094.
13. Monti P., Leone B.E., Zerbi A., et al. Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell. J. Immunol. 2004, 172:7341-7349.
14. Brinkman-Van der Linden E.C., Varki A. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins. J. Biol. Chem. 2000, 275:8625-8632.
15. Inaba T., Sano H., Kawahito Y., et al. Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:2736-2741.
16. Hidari K.I., Murata T., Yoshida K., et al. Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection. Glycobiology 2008, 18:779-788.
17. Kitagawa H., Nakada H., Numata Y., et al. Immunoaffinity isolation of a sialyl-Le(a) oligosaccharide from human milk. J. Biochem. 1988, 104:591-594.
18. Tanaka N., Nakada H., Inoue M., et al. Binding characteristics of an anti-Siaalpha2-6GalNAcalpha-Ser/Thr (sialyl Tn) monoclonal antibody (MLS 132). Eur. J. Biochem. 1999, 263:27-32.
19. Chen X., Doffek K., Sugg S.L., et al. Phosphatidylserine regulates the maturation of human dendritic cells. J. Immunol. 2004, 173:2985-2994.
20. Angata T., Varki A. Cloning, characterization, and phylogenetic analysis of Siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways. J. Biol. Chem. 2000, 275:22127-22135.
21. Blixt O., Collins B.E., van den Nieuwenhof I.M., et al. Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein. J. Biol. Chem. 2003, 278:31007-31019.
22. Ishida A., Ohta M., Toda M., et al. Mucin-induced apoptosis of monocyte-derived dendritic cells during maturation. Proteomics 2008, 8:3342-3349.
23. Rughetti A., Pellicciotta I., Biffoni M., et al. Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells. J. Immunol. 2005, 174:7764-7772.
24. Agrawal B., Krantz M.J., Reddish M.A., et al. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat. Med. 1998, 4:43-49.
25. Nakada H., Inoue M., Numata Y., et al. Cancer-associated glycoproteins defined by a monoclonal antibody, MLS 128, recognizing the Tn antigen. Biochem. Biophys. Res. Commun. 1992, 187:217-224.
26. Gringhuis S.I., den Dunnen J., Lifjens M., et al. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 2007, 26:605-616.
27. Yamashita K., Sakuramoto S., Kikuchi S., et al. Surgical resection of stage IV gastric cancer and prognosis. Anticancer Res. 2007, 27:4381-4386.
28. Katoh H., Yamashita K., Kokuba Y., et al. Surgical resection of stage IV colorectal cancer and prognosis. World J. Surg. 2008, 32:1130-1137.
29. Waraya M., Yamashita K., Katagiri H., et al. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer. Ann. Surg. Oncol. 2009, 16:1231-1240.